文献速递急腹症与外科感染围术期管理与 ERAS

COVID-19患者急诊手术围术期并发症与死亡风险

Perioperative Morbidity and Mortality of Patients With COVID-19 Who Undergo Urgent and Emergent Surgical Procedures.
PubMed 文献 · Ann Surg · 2021-01-01

该研究纳入纽约两家医院2020年3月17日至4月15日接受急诊手术的468例患者,其中36例(7.7%)确诊COVID-19。COVID-19患者围术期死亡率16.7%、严重并发症发生率58.3%,均显著高于对照组,且相当比例患者术后才被检出。

要点

  • COVID-19患者急诊手术后严重并发症和死亡风险显著升高
  • 术前常规筛查可提高COVID-19术前检出率
  • 部分COVID-19患者直至术后才被识别

核心结论

  • COVID-19与急诊手术后严重围术期并发症和死亡风险增加相关。
  • 相当数量COVID-19患者直至术后才被识别。

研究设计与样本

  • 回顾性队列研究,纳入纽约两家医院2020年3月17日至4月15日接受急诊手术的468例患者。
  • 比较围术期检出COVID-19患者与对照组的死亡率、并发症和ICU入住率。

主要发现

  • 468例中36例(7.7%)确诊COVID-19,其中55.6%术前检出、44.4%术后检出。
  • COVID-19患者围术期死亡率为16.7%,对照组为1.4%(aRR=9.29;95%CI 5.68-15.21)。
  • COVID-19患者严重并发症发生率为58.3%,对照组为6.0%(aRR=7.02;95%CI 4.96-9.92)。
  • 心脏骤停、脓毒症/休克、呼吸衰竭、肺炎、急性呼吸窘迫综合征和急性肾损伤在COVID-19患者中更常见。
  • ICU入住率COVID-19患者为36.1%,对照组为16.4%(aRR=1.34;95%CI 0.86-2.09)。

关键数值与推荐

  • 常规术前COVID-19实验室筛查实施前术前确诊率为7.7%,实施后为65.2%(P=0.0008)。

临床怎么用

  • 急诊手术前应常规进行COVID-19筛查以识别感染者。
  • 对COVID-19患者急诊手术需警惕高并发症和死亡风险,加强围术期监护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the perioperative morbidity and mortality of patients with COVID-19 who undergo urgent and emergent surgery. SUMMARY BACKGROUND DATA: Although COVID-19 infection is usually associated with mild disease, it can lead to severe respiratory complications. Little is known about the perioperative outcomes of patients with COVID-19. METHODS: We examined patients who underwent urgent and emergent surgery at 2 hospitals in New York City from March 17 to April 15, 2020. Elective surgical procedures were cancelled throughout and routine, laboratory based COVID-19 screening was instituted on April 1. Mortality, complications, and admission to the intensive care unit were compared between patients with COVID-19 detected perioperatively and controls. RESULTS: Among 468 subjects, 36 (7.7%) had confirmed COVID-19. Among those with COVID-19, 55.6% were detected preoperatively and 44.4% postoperatively. Before the routine preoperative COVID-19 laboratory screening, 7.7% of cases were diagnosed preoperatively compared to 65.2% after institution of screening (P = 0.0008). The perioperative mortality rate was 16.7% in those with COVID-19 compared to 1.4% in COVID-19 negative subjects [aRR = 9.29; 95% confidence interval (CI), 5.68-15.21]. Serious complications were identified in 58.3% of COVID-19 subjects versus 6.0% of controls (aRR = 7.02; 95%CI, 4.96-9.92). Cardiac arrest, sepsis/shock, respiratory failure, pneumonia, acute respiratory distress syndrome, and acute kidney injury were more common in those with COVID-19. The intensive care unit admission rate was 36.1% in those with COVID-19 compared to 16.4% of controls (aRR = 1.34; 95%CI, 0.86-2.09). CONCLUSIONS: COVID-19 is associated with an increased risk for serious perioperative morbidity and mortality. A substantial number of patients with COVID-19 are not identified until after surgery.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Knisely A, Zhou ZN, Wu J, et al. Perioperative Morbidity and Mortality of Patients With COVID-19 Who Undergo Urgent and Emergent Surgical Procedures. Ann Surg. 2021. PMID: 33074900. doi:10.1097/SLA.0000000000004420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。